Molecular Imaging

SIIM: Informatics key to future of theranostics

Informatics will play a key role in shaping the future of theranostics.

May 22, 2025

Tyler Bradshaw, PhD, and Eliot Siegel, MD, introduced the concept of 'theranostics informatics' May 22 at SIIM.

International Isotopes posts 12% increase in Q1 revenue

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes has posted increased revenue for its 2025 first quarter.

May 21, 2025

ITM, Radiopharm ink Lu-177 supply agreement

By AuntMinnie.com staff writers

Under the terms of the agreement, ITM will supply Radiopharm Theranostics with non-carrier-added lutetium-177 (Lu-177).

May 20, 2025

FAPI-SPECT/CT shows promise diagnosing gastrointestinal cancer

FAPI-SPECT/CT is comparable to FDG-PET/CT for detecting lesions in patients with gastrointestinal cancer, a study shows.

May 19, 2025

Representative F-18 FDG-PET/CT and Tc-99m FAPI-SPECT/CT scans for five study patients with gastrointestinal cancer. FDG-PET/CT and FAPI-SPECT/CT images show that uptake occurred in metastatic lymph nodes (LNs) (patient number 50, D) and bone metastases (patient number 33, C). FAPI-SPECT/CT outperformed FDG-PET/CT in detecting liver metastases (patient number 3, A; and 15,B) and peritoneal spread metastases (patient number 27, E). Red arrows indicate foci additionally found by FAPI-SPECT/CT.

Algernon to acquire NoBrainer Imaging Centers

By AuntMinnie.com staff writers

Algernon Pharmaceuticals has entered an agreement to acquire NoBrainer Imaging Centers.

May 14, 2025

ISMRM: Barriers face synthetic amyloid PET image development

Work on developing synthetic amyloid PET images from MRI scans is in its early stages.

May 14, 2025

AI models can generate synthetic equivalents to PET images from routinely acquired T1W MRI scans.

ISMRM: AI spots ischemic heart disease on low GBCA dose images

By Erik L. Ridley

An AI-based framework was highly accurate for detecting myocardial ischemia, even on images acquired with 90% less gadolinium.

May 14, 2025

Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.

ISMRM: Trimodal PET-MR-FUS may be feasible therapy monitoring option

By Amerigo Allegretto

Researchers at ISMRM 2025 touted the success of a trimodal MR-PET-FUS system that could have applications for therapy monitoring.

May 10, 2025

Researchers at ISMRM highlighted the success of a trimodal MR-PET-FUS system built around a low-field MRI scanner. MR (top) and PET (bottom) images were acquired simultaneously before and after FUS heating.

Beta-amyloid testing results have limited emotional impact for patients

By Maryam Payne

Receiving results from amyloid beta testing did not have a significant negative emotional impact on patients, whether negative or positive, findings from a new study show.

May 9, 2025

Brain Amyloid Plaque Neuron

PET/MRI reveals how brain stimulation technique works

PET/MRI scans have revealed the mechanism underlying a brain stimulation technique for treating neurological and psychiatric conditions.

May 9, 2025

2025 05 09 Brain Stimulation Thumbnail

Whole-body PET shows how naloxone blocks opioids

PET imaging has shown for the first time how the opioid overdose treatment naloxone blocks neuroreceptors throughout the body.

May 9, 2025

Naloxone2 Thumbnail

Shine to buy Lantheus’ SPECT business

By AuntMinnie.com staff writers

Medical isotope developer Shine Technologies has entered an agreement to acquire Lantheus Holdings’ SPECT business.

May 7, 2025

Page 1 of 604